03/12/2025
Relative value of novel systemic immune-inflammatory indices and classical hematological parameters in predicting depression, su***de attempts and treatment response
https://www.nature.com/articles/s41598-024-70097-z #:~:text=Systemic%20immune%2Dinflammation%20index%20(SII,an%20increased%20risk%20of%20depression.
This study compared the power of the novel inflammatory markers systemic immune inflammation index (SII) and the system inflammation response index (SIRI) versus the classical hematological indices neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and platelet counts in distinguishing between major depressive disorder (MDD) with and without su***de attempts and distinguishing the non-response to selective serotonin reuptake inhibitor (SSRI) treatment. A total of 139 young adult MDD patients and 54 healthy controls (HC) were included. We found that, in comparison to HC, baseline NLR, PLR, SII, and SIRI were significantly higher in MDD patients, but only NLR and SII had area under the ROC curve (AUC) values greater than 0.7. MDD patients with su***de attempts (SA) showed significantly higher baseline MLR and SIRI, and a tendency to increase NLR compared to those without SA. In terms of AUC, sensitivity, and specificity, NLR was better than MLR, SIRI, SII, and PLR in distinguishing SA. Non-responders to SSRI treatment showed a significant increase in baseline platelet count and PLR compared to responders with an AUC greater than 0.7. These findings highlight the potential benefit of combining novel and classical hematological indices in predicting depression, su***de attempts and treatment response.
".....Systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) are two novel inflammatory indexes and convenient measurements based on peripheral blood neutrophils, monocyte counts, platelet counts, and lymphocyte counts. The SII (calculated as neutrophil count ร platelet count/lymphocyte count) was first proposed as a powerful prognostic indicator of poor outcome in patients with hepatocellular carcinoma in 2014 by Hu et al. 23. Similarly, SIRI (calculated as neutrophil count ร monocyte count/lymphocyte) was first described by Qi et al.24. Given that SII brings together three inflammatory peripheral cell counts, including neutrophil, platelet, and lymphocyte counts, into an equation and SIRI incorporates neutrophil, monocyte, and lymphocyte counts into an equation, they should offer a more comprehensive reflection of the inflammatory state.
Several studies confirmed that a higher SII was significantly associated with an increased risk for depression in patients with diabetes mellitus25, stroke26, and tuberculosis27. In addition, a study by Li et al.28 demonstrated that high levels of SII and SIRI were associated with an increased risk of depression...."
This study compared the power of the novel inflammatory markers systemic immune inflammation index (SII) and the system inflammation response index (SIRI) versus the classical hematological indices neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio...